Described herein are pharmaceutical packaging programs which stop oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive drugs, such techniques such as a syringe with the oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really minimal permeability to oxygen and compri